Carmat SA (ALCAR.PA)
EUR 1.0
(-1.09%)
EUR 1.0
(-1.09%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -30.97 Million EUR | 42.71% |
| 2022 | -54.14 Million EUR | -3.18% |
| 2021 | -52.47 Million EUR | -161.36% |
| 2020 | -20.07 Million EUR | -1646.7% |
| 2019 | -1.14 Million EUR | -26.9% |
| 2018 | -905.82 Thousand EUR | -25.15% |
| 2017 | -723.82 Thousand EUR | 92.88% |
| 2016 | -10.17 Million EUR | -12.63% |
| 2015 | -9.03 Million EUR | 53.84% |
| 2014 | -19.56 Million EUR | -86.29% |
| 2013 | -10.5 Million EUR | 36.22% |
| 2012 | -16.46 Million EUR | -1.17% |
| 2011 | -16.27 Million EUR | -164.99% |
| 2010 | -6.14 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -22.39 Million EUR | 0.0% |
| 2023 Q2 | -25.33 Million EUR | 0.0% |
| 2023 Q4 | -4.98 Million EUR | 0.0% |
| 2023 FY | -31.01 Million EUR | 42.71% |
| 2022 FY | -54.14 Million EUR | -3.18% |
| 2022 Q2 | -27.73 Million EUR | 0.0% |
| 2022 Q4 | -26.4 Million EUR | 0.0% |
| 2021 Q4 | -29.13 Million EUR | 0.0% |
| 2021 FY | -52.47 Million EUR | -161.36% |
| 2021 Q2 | -562.91 Thousand EUR | 0.0% |
| 2020 Q4 | -7.35 Million EUR | 0.0% |
| 2020 Q2 | -478.6 Thousand EUR | 0.0% |
| 2020 FY | -20.07 Million EUR | -1646.7% |
| 2019 Q2 | -593.58 Thousand EUR | 0.0% |
| 2019 Q4 | -555.95 Thousand EUR | 0.0% |
| 2019 FY | -1.14 Million EUR | -26.9% |
| 2018 FY | -905.82 Thousand EUR | -25.15% |
| 2018 Q2 | -13.65 Million EUR | 0.0% |
| 2018 Q4 | -246.69 Thousand EUR | 0.0% |
| 2017 Q2 | -10.67 Million EUR | 0.0% |
| 2017 FY | -723.82 Thousand EUR | 92.88% |
| 2017 Q4 | -11.18 Million EUR | 0.0% |
| 2016 Q2 | -8.26 Million EUR | 0.0% |
| 2016 FY | -10.17 Million EUR | -12.63% |
| 2016 Q4 | -9.47 Million EUR | 0.0% |
| 2015 FY | -9.03 Million EUR | 53.84% |
| 2015 Q4 | -7.25 Million EUR | 0.0% |
| 2015 Q2 | -6.12 Million EUR | 0.0% |
| 2014 FY | -19.56 Million EUR | -86.29% |
| 2014 Q2 | -7.94 Million EUR | 0.0% |
| 2014 Q4 | -6.07 Million EUR | 0.0% |
| 2013 Q1 | -3.34 Million EUR | -0.0% |
| 2013 Q4 | -7.74 Million EUR | -131.73% |
| 2013 FY | -10.5 Million EUR | 36.22% |
| 2013 Q3 | -3.34 Million EUR | -21.44% |
| 2013 Q2 | -2.75 Million EUR | 17.66% |
| 2012 Q4 | -3.34 Million EUR | 18.77% |
| 2012 Q1 | -4.11 Million EUR | 0.0% |
| 2012 FY | -16.46 Million EUR | -1.17% |
| 2012 Q3 | -4.11 Million EUR | 0.0% |
| 2012 Q2 | -4.11 Million EUR | 0.0% |
| 2011 Q1 | -4.06 Million EUR | 0.0% |
| 2011 Q3 | -4.06 Million EUR | 0.0% |
| 2011 Q4 | -4.11 Million EUR | -1.17% |
| 2011 FY | -16.27 Million EUR | -164.99% |
| 2011 Q2 | -4.06 Million EUR | 0.0% |
| 2010 FY | -6.14 Million EUR | 0.0% |
| 2010 Q4 | -4.06 Million EUR | -164.99% |
| 2010 Q1 | -1.53 Million EUR | 0.0% |
| 2010 Q3 | -1.53 Million EUR | 0.0% |
| 2010 Q2 | -1.53 Million EUR | -0.0% |
| 2009 Q4 | -1.53 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Affluent Medical SA | -1.2 Million EUR | -2480.917% |
| Bluelinea Société Anonyme | -3.84 Million EUR | -704.946% |
| Diagnostic Medical Systems S.A. | 15.84 Million EUR | 295.487% |
| Euromedis Groupe | 3.57 Million EUR | 967.152% |
| Eurobio Scientific Société anonyme | 53.96 Million EUR | 157.39% |
| Ikonisys S.A. | 255.82 Thousand EUR | 12206.228% |
| Implanet S.A. | 3.13 Million EUR | 1088.857% |
| Median Technologies SA | -2.55 Million EUR | -1114.073% |
| SpineGuard SA | 3.37 Million EUR | 1016.558% |
| Theraclion SA | -1.08 Million EUR | -2766.663% |
| Euroapi S.A. | 164.6 Million EUR | 118.816% |
| Guerbet SA | 197.14 Million EUR | 115.71% |
| Ion Beam Applications SA | 134.44 Million EUR | 123.037% |
| Koninklijke Philips N.V. | 7.44 Billion EUR | 100.416% |
| Sequana Medical NV | 548.04 Thousand EUR | 5751.137% |